FeesSafety
Pluang+

Aeluma to report Q1 fiscal 2027 results on Nov 12 with a conference call scheduled.

Company Fundamentals
29 Oct 2026, 14:00 WIB
GlobeNewsWire
View Source
Neutral
Aeluma to report Q1 fiscal 2027 results on Nov 12 with a conference call scheduled.

Aeluma, a semiconductor company, will announce its financial results for the first quarter of fiscal 2027 on November 12, 2026, after U.S. markets close. The company will hold a conference call the same day to discuss the results and business outlook. This update is important for investors tracking Aeluma's progress in high-performance semiconductor technologies across various industries. The call will be accessible via phone and webcast, with a replay available on Aeluma's website.

Aeluma's upcoming Q1 fiscal 2027 financial results announcement is noted here with Pluang's Technology sector market data as of Oct 29, 2026 17:21 WIB: out of 150 priced US tech stocks, 24 rose and 123 fell. Among notable movers, OKTA traded at USD 210.32 with a 1-day change of -5.54% and Pluang order activity showing 0% Sell / 100% Buy, while GTLB was at USD 54.99, down 5.14% with the same order activity. HUBS closed at USD 236.00, down 5.08%, with a typical hold time on Pluang of 79 days.

More News

NCH performs US first tricuspid valve repair with PASCAL Precision system after FDA approval

NCH performs US first tricuspid valve repair with PASCAL Precision system after FDA approval

Naples Comprehensive Health (NCH) has completed the first tricuspid valve repair in the US using the PASCAL Precision system following FDA approval. This minimally invasive catheter-based procedure offers a new treatment option for patients with seve...

Market News
Bullish
1 hour ago
Immunocore to present Phase 1 data on brenetafusp and KIMMTRAK combo for metastatic uveal melanoma at SITC 2026

Immunocore to present Phase 1 data on brenetafusp and KIMMTRAK combo for metastatic uveal melanoma at SITC 2026

Immunocore Holdings will present Phase 1/2 clinical trial data for brenetafusp alone and combined with KIMMTRAK in treating metastatic uveal melanoma at the 2026 Society for Immunotherapy of Cancer meeting. This trial evaluates safety and efficacy in...

Company Fundamentals
Bullish
1 hour ago
Collegium Pharmaceutical and Boston Legacy FC expand partnership to support neurodivergent youth in Massachusetts sports.

Collegium Pharmaceutical and Boston Legacy FC expand partnership to support neurodivergent youth in Massachusetts sports.

Collegium Pharmaceutical and Boston Legacy FC have extended their partnership to include youth coach training, an annual Sports for All Summit, and sensory inclusion programs aimed at supporting neurodivergent children, especially those with ADHD, in...

Others
Bullish
2 hours ago
Gilat Satellite Networks to attend Deutsche Bank Global Space and Defense Tech Summit in NYC

Gilat Satellite Networks to attend Deutsche Bank Global Space and Defense Tech Summit in NYC

Gilat Satellite Networks announced that its CEO Adi Sfadia and CFO Gil Benyamini will attend the Deutsche Bank Global Space and Defense Tech Summit on November 18, 2026, in New York City. The event will feature one-on-one and group meetings, providin...

Market News
Neutral
2 hours ago
Boralex buys Wind2 to boost UK wind energy projects by 350 MW, expanding its renewable footprint.

Boralex buys Wind2 to boost UK wind energy projects by 350 MW, expanding its renewable footprint.

Boralex Inc. has acquired Wind2, a UK-based renewable energy developer with about 350 MW of advanced wind projects across Scotland, England, and Wales. This acquisition strengthens Boralex's presence and capabilities in the UK, aligning with its stra...

Company Fundamentals
Bullish
3 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App